Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.82 USD | -0.15% | +8.77% | -0.15% |
May. 28 | Axogen, Inc. Announces the Opening of its Axogen Processing Center | CI |
May. 16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
Business Summary
Number of employees: 427
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peripheral Nerve Regeneration and Repair
100.0
%
| 139 | 100.0 % | 159 | 100.0 % | +14.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 139 | 100.0 % | 159 | 100.0 % | +14.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Karen Zaderej
CEO | Chief Executive Officer | 62 | 06-04-30 |
Nir Naor
DFI | Director of Finance/CFO | 49 | Dec. 05 |
Marc Began
CMP | Compliance Officer | 57 | 23-03-05 |
Ivica Ducic
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-04 |
Gregory Freitag
BRD | Director/Board Member | 62 | 10-05-31 |
Todd Puckett
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | 21-12-31 | |
Jens Kemp
SAM | Sales & Marketing | - | 23-02-12 |
Erick DeVinney
PRN | Corporate Officer/Principal | 48 | 07-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Thomas
BRD | Director/Board Member | 68 | 20-09-29 |
Director/Board Member | 63 | 16-08-31 | |
John Johnson
BRD | Director/Board Member | 66 | 21-07-18 |
Guido Neels
BRD | Director/Board Member | 75 | 15-08-25 |
Karen Zaderej
CEO | Chief Executive Officer | 62 | 06-04-30 |
Gregory Freitag
BRD | Director/Board Member | 62 | 10-05-31 |
Alan Levine
BRD | Director/Board Member | 56 | 19-05-14 |
William Burke
BRD | Director/Board Member | 55 | 22-07-10 |
Joseph Tyndall
BRD | Director/Board Member | 55 | 22-12-12 |
Kathy Weiler
BRD | Director/Board Member | 54 | Dec. 19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,704,574 | 39,867,535 ( 91.22 %) | 0 | 91.22 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.15% | 299M | |
+7.31% | 217B | |
+12.99% | 190B | |
+19.71% | 143B | |
+30.60% | 111B | |
+0.65% | 64.59B | |
+15.23% | 52.36B | |
+2.06% | 48.45B | |
-5.49% | 38.03B | |
-0.22% | 35.6B |
- Stock Market
- Equities
- AXGN Stock
- Company AxoGen, Inc.